24 news items
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
BMY
23 May 24
that help provide long-term benefit for patients."
Key data being presented by Bristol Myers Squibb at ASCO
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
ABBV
BMY
17 May 24
expects robust growth to resume in 2025, with projections aligning with management’s long-term guidance of a high single-digit compound annual
Bristol Myers Squibb Presents New 4-Year Sotyktu Data Demonstrate Durable Response Rates And Consistent Safety In Moderate-To-Severe Plaque Psoriasis
BMY
16 May 24
than seven out of 10 patients for Psoriasis Area and Severity Index (PASI) 75 in the POETYK PSO long-term extension trial
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
BMY
16 May 24
patients for Psoriasis Area and Severity Index (PASI) 75 in the POETYK PSO long-term extension trial
Bristol Myers Squibb Shares Update On Phase 3 CheckMate -73L Trial; Says Trial Did Not Meet Its Primary Endpoint Of Progression-Free Survival In Unresectable, Locally Advanced Stage III Non-Small Cell Lung Cancer
BMY
10 May 24
Squibb. "There remains a critical need to improve long-term outcomes for these patients and we believe these results will help inform future drug
c1g6hn6ulicn83wh2h7u64he f6w
BMY
10 May 24
, Bristol Myers Squibb. "There remains a critical need to improve long-term outcomes for these patients and we believe these results will help inform
koyiwlmz04cg63dgmi3ouheoec0c3e39x4po79mqoq84nyfrfa8ojm91
BMY
29 Apr 24
the immune system, reflecting a key component of our immunology research strategy, which we believe may offer long term benefit while mitigating unintended
y5dauy4l2124vup00
BMY
25 Apr 24
to Strengthen the Company's Long-Term Growth Profile
qkwzd
BMY
NVS
23 Apr 24
business and pipeline gives us continued confidence in our mid- and long-term growth outlook,” he said.
Heart failure drug Entresto
u2bxqyklb9zsnmtow h1vrrow6518jh1i3i6
BMY
8 Apr 24
) released interim long-term safety, tolerability, and metabolic outcomes data from its Phase 3 EMERGENT program evaluating KarXT (xanomeline-trospium
xm6y3dr
BMY
6 Apr 24
Long-term treatment
zqknbchk5f6saph62
BMY
2 Apr 24
cord compression symptoms due to EMH masses occurring in 1.9% of patients (BELIEVE and REBLOZYL long-term follow-up study
fu6g6oc6mmkyvscupcm0ufo3oru5xzb3s2c0bk2wb
BMY
2 Apr 24
patients around the world. As we navigate an increasingly complex global landscape, our ESG strategy has never been more important to driving long
9v85lnultabi5qt3thh2dnjv4182lp02nu27y bwas8lsfffh0jn6n54
BMY
25 Mar 24
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling
1y1q xwuv4xy
BMY
20 Mar 24
relapsed and/or refractory disease, it is critical that we continue to add innovative treatment options to our arsenal that can potentially provide long